Lumibird SA
PAR:LBIRD
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.8
14.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Lumibird SA
Total Liabilities & Equity
Lumibird SA
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Lumibird SA
PAR:LBIRD
|
Total Liabilities & Equity
€405.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
22%
|
CAGR 10-Years
23%
|
||
Ses Imagotag SA
PAR:SESL
|
Total Liabilities & Equity
€1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
29%
|
CAGR 10-Years
24%
|
||
Groupe SFPI SA
PAR:SFPI
|
Total Liabilities & Equity
€607.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
51%
|
||
Gea Grenobloise Electronique Automatisme SA
PAR:GEA
|
Total Liabilities & Equity
€92.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
||
I2S SA
PAR:ALI2S
|
Total Liabilities & Equity
€20.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
||
Vusiongroup SA
PAR:VU
|
Total Liabilities & Equity
€1.1B
|
CAGR 3-Years
32%
|
CAGR 5-Years
27%
|
CAGR 10-Years
25%
|
Lumibird SA
Glance View
Lumibird SA engages in the design, manufacturing and marketing of lasers. The company is headquartered in Lannion, Bretagne and currently employs 914 full-time employees. The firm offers a range of products, including compact pulsed Nd, double-pulse Nd, tunable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules and intense pulsed light instruments, among others. Lumibird provides lasers to industrial and scientific clients, as well as the medical sector, among others. The firm operates worldwide through the subsidiaries, such as Quantel Medical, which specializes in the development and marketing of diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, which designs and produces fiber lasers, glass laser systems and tunable lasers, and Quantel Derma AT, which focuses on the development, production and sales of the laser technology products in the areas of dermatology and aesthetics.
See Also
What is Lumibird SA's Total Liabilities & Equity?
Total Liabilities & Equity
405.2m
EUR
Based on the financial report for Dec 31, 2023, Lumibird SA's Total Liabilities & Equity amounts to 405.2m EUR.
What is Lumibird SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
23%
Over the last year, the Total Liabilities & Equity growth was 9%. The average annual Total Liabilities & Equity growth rates for Lumibird SA have been 10% over the past three years , 22% over the past five years , and 23% over the past ten years .